Background 11␤-Hydroxysteroid dehydrogenases (11␤-HSDs) catalyse the interconversion of active glucocorticoids (cortisol in man; corticosterone in mice) with inactive metabolites (cortisone in man; 11-dehydrocorticosterone in mice). Two isozymes have been cloned: 11␤-HSD1 reactivates cortisone to cortisol in liver and enhances glucocorticoid receptor activation; 11␤-HSD2 inactivates cortisol to cortisone in kidney and protects mineralocorticoid receptors from cortisol. Mutations in 11␤-HSD2 explain the hypertension in the syndrome of apparent mineralocorticoid excess. However, this may not be the only influence of 11␤-HSDs on blood pressure. In blood vessels, glucocorticoids enhance noradrenaline-induced constriction and may inhibit endothelium-dependent dilatation. We have described 11␤-HSD activity in vascular smooth muscle and demonstrated effects of the enzyme inhibitor carbenoxolone on responses to noradrenaline in rat and man. However, it is unclear which isozyme of 11␤-HSD is responsible for these effects. In this report, we studied vasoconstrictor and vasodilator responses in aortae from mice with transgenic inactivation (knockout) of either the 11␤-HSD1 or 11␤-HSD2 genes.
Methods Gene targeting of 11␤-HSD1 and 11␤-HSD2 was accomplished as previously described. Knockout (−/−) animals were compared with weightmatched wild type mice (+/+). Only the 11␤-HSD2 −/− mice were hypertensive (systolic pressure 155 vs 125 mm Hg in +/+). 11␤-HSD activity was measured in fragments of aorta homogenised and incubated at 500 g protein/ml with 3 H-corticosterone (12 nM) and NAD (1 mM). Conversion to 3 H-11-dehydrocorticosterone was determined by HPLC. To measure vascular function, aortae were isolated from male mice, and one ring with intact endothelium and one de-endothelialised ring from each was mounted in a myograph.
Results 11␤-HSD activity in aortae was reduced in both 11␤-HSD1 −/− (9.0 ± 0.5%; n = 4, P Ͻ 0.01) and 11␤-HSD2 −/− (20.0 ± 2.5%; n = 4, P Ͻ 0.03) mice compared with +/+ mice (28.0 ± 2.0%; n = 6). In aortae from +/+ mice, noradrenaline (10 M); the response to noradrenaline was not influenced by removal of the endothelium or incubation with L-NNA; and it was associated with impaired vasodilator sensitivity to acetylcholine (10 −9 − 3 × 10 −5 M)(pD 2 7.9 ± 0.1 vs 8.2 ± 0.1, n = 8, P Ͻ 0.02).
Conclusions These data demonstrate that both isozymes of 11␤-HSD are active in mouse aorta. Endothelial nitric oxide synthesis exerts tonic inhibition of noradrenaline-induced contraction in this model, and this effect is impaired in mice with 11␤-HSD2 but not 11␤-HSD1 deficiency. Intact responses to other vasoconstrictors suggest that this is not a consequence of hypertension in these animals. Thus it appears that 11␤-HSD2 is responsible for protection of corticosteroid receptors in blood vessels.
Since we have demonstrated impaired inactivation of cortisol by 11␤-HSD in patients with essential hypertension, it is possible that this mechanism contributes to 'endothelial dysfunction' and enhanced noradrenergic vasoconstriction in these patients.
Mechanisms of action of angiotensin II in human isolated resistance arteries: contributions from tyrosine and map kinases RS Garcha, AD Hughes and PS Sever
Clinical Pharmacology, National Heart and Lung Institute, Imperial College of Science, Technology & Medicine, London W2 1NY, UK Angiotensin II (AII) plays an important role in blood pressure regulation and extracellular fluid volume control. In the vasculature AII has been reported to exert both contractile and growth-promoting effects via actions on AT 1 receptors. 1 Increasing evidence has indicated that AII activates a number of signalling pathways classically associated with proliferation such as tyrosine phosphorylation and activation of MAP kinases. However, the possible role of these signalling pathways in the vasoconstrictor action of AII in man has not been explored.
Human resistance arteries (internal diameter ෂ 250 m) were isolated from subcutaneous fat and mounted in a Mulvany myograph containing physiological saline (PSS). In some studies vessels were also loaded with fura-2-AM (5 M) for 2 h to allow simultaneous measurement of isometric tension and intracellular calcium [Ca 2+ ] i using a fluorescence microscopy. Data are means ± SEM of n observations. AII (100 pM-100 nM) induced concentrationdependent contraction in human resistance arteries (maximum contraction = 103 ± 4% KPSS, EC 50 = 1.3 nM, n = 20). AII (100 nM) increased [Ca 2+ ] i by 72 ± 13% of the response to 118 mM K + (n = 8). A voltage-operated calcium channel antagonist, amlodipine (10 M), inhibited the AII-induced rise in force and [Ca 2+ ] i by 62 ± 10% and 41 ± 7% respectively (n = 3). Ni 2+ (2mM) a blocker of voltage-and receptoroperated calcium channels inhibited AII-induced The spontaneously hypertensive stroke prone rat (SHRSP) is a model of genetic hypertension which displays endothelial dysfunction and relative nitric oxide (NO) deficiency, despite an upregulation of eNOS mRNA and eNOS enzymatic activity. 1 The aim of this study was to test the hypothesis that the decreased NO availability observed in SHRSP was related to increased superoxide anion (O 2 − ) levels and subsequent alterations in NO scavenging.
Increased endothelial superoxide production in SHRSP
O 2 − was quantified in 5 mm aortic rings from 3-4 month-old male and female WKY and SHRSP by lucigenin chemiluminescence in a liquid scintillation counter. 2 All data shown is expressed as O 2 − production in nMoles/mg tissue/min, and as mean ± SEM for each group. 27 male WKY, 30 female WKY, 31 male SHRSP and 29 female SHRSP were used for these studies. The blood pressures of these animals, measured by tail cuff plethysmography, were 127 ± 3 mm Hg, 120 ± 1 mm Hg, 160 ± 5 mm Hg, and 142 ± 3 respectively for male and female WKY and SHRSP. O 2 − generation was significantly higher in male increases in force and [Ca 2+ ] i by 84 ± 13% and 99 ± 1% respectively (n = 4). Removal of extracellular Ca 2+ completely abolished responses to AII (n = 4). Contraction in response to AII (100 pM-100 nM) was also inhibited insurmountably by a selective tyrosine kinase inhibitor, genistein (10 M; maximum inhibition = 75 ± 6%, n = 5) and by a selective MAP kinase kinase inhibitor, PD98059 (30 M; maximum inhibition = 58 ± 9%, n = 5). 2 In contrast, responses to noradrenaline (1 nM-10 M) or 118 nM K + were not affected by genistein (10 M) or PD98059 (30 M).
These studies indicate that AII contracts human resistance arteries by inducing Ca 2+ entry through both voltage-and receptor-operated channels. Contraction in response to AII, but not noradrenaline, also involves, in part, activation of a tyrosine kinase(s) sensitive to genistein and MAP kinase. The mechanism by which AT 1 receptors induce activation of tyrosine kinase and MAP kinase require further study as does the role of these signalling pathways in the contractile process in human vascular smooth muscle. SHRSP (4.11 ± 0.24) compared to male WKY (1.22 ± 0.08, 95% CI: 2.22, 3.67; P Ͻ 0.0001), and in female SHRSP (3.84 ± 0.28) compared to female WKY (0.8 ± 0.08, 95% CI: 2.25, 3.91; P Ͻ 0.0001). The gender difference observed in O 2 − generation, with males producing more O 2 − than females, was found to be statistically significant in WKY rats only (95% CI: 0.16, 0.67; P = 0.0057). Removal of the endothelium had no effect on WKY but significantly reduced O 2 − in male (3.86 ± 0.12 vs 1.35 ± 0.09, 95% CI: 2.29, 2.81; P Ͻ 0.0001) and female (3.58 ± 0.15 vs 1.41 ± 0.10, 95% CI: 1.82, 2.52; P Ͻ 0.0001) SHRSP. Treatment with L-NAME (100 M) to block NO synthesis did not effect O 2 − production in WKY rats but significantly reduced O 2 − production in male (4.13 ± 0.17 vs 1.32 ± 0.15, 95% CI: 2.43, 3.19; P Ͻ 0.0001) and female (3.98 ± 0.08 vs 1.38 ± 0.06, 95% CI: 2.36, 2.83; P Ͻ 0.0001) SHRSP. Similarly treatment with LNMMA (1 mM) also significantly reduced O 2 − production from SHRSP (4.17 ± 0.17 vs 1.83 ± 0.15, 95% CI: 1.68, 2.99; P = 0.0003). Treatment with L-Arginine (10 −6 M) had no effect on O 2 − generation in either WKY or SHRSP.
These results suggest that increased O 2 − production may be a primary cause of endothelial dysfunction and of relative NO deficiency in this model of genetic hypertension, and that the cellular and enzymatic source of this O 2 − excess are the endothelial cells and eNOS respectively. Background Blunted vasoconstrictor responses of human forearm resistance vasculature to N G -monomethyl-L-arginine, assessed either singly 1 or relative to noradrenaline 2 have been reported in essential hypertension. This has been interpreted as evidence of reduced basal endothelial NO biosynthesis in this condition. We measured forearm blood flow responses to brachial artery administration of N Gmonomethyl-L-arginine and noradrenaline to determine whether such altered sensitivity is a consistent finding.
Forearm vasoconstrictor responses
Methods The protocol was approved by the local research ethics committees. Healthy normotensive volunteers (n = 32, BP 130 ± 14/75 ± 8, mean ± SD) were recruited by local advertisement in Southeast London and otherwise healthy patients with uncomplicated essential hypertension (n = 32, BP 176 ± 22/102 ± 14) were recruited consecutively from the Guy's Hospital hypertension clinic. The groups were similar as regards age (41.4 ± 10.5 in the control and 45.2 ± 10.6 in the hypertensive group), gender (20 men and 12 women in each group), ethnic origin (26 white, 6 Afro-Caribbean black in the control and 28 white, 4 Afro-Caribbean black in the hypertensive group), serum total cholesterol (4.99 ± 1.1 mmol L −1 in the control, 5.39 ± 0.8 mmol L −1 in the hypertensive group) and smoking status (27 non-smokers and 5 smokers in both the control and hypertensive groups). Antihypertensive treatment was discontinued at least 2 weeks before study in previously treated patients (n = 13). No subjects were taking any medications at the time of study. Cumulative doses of noradrenaline (6 min infusions of 60, 120 and 240 pmol min ) were administered via a constant rate infusion pump into the brachial artery, and fore-1.5 Di30ct and indirect demonstration of increased sodium channel activity in black subjects with the T594M epithelial sodium channel mutation ) and percentage reduction in blood flow ratio (infused: control arm) relative to the immediately preceding baseline. Repeated measures analysis of variance was used to seek an interaction between drug (L-NMMA and noradrenaline) and hypertension in determining vascular responses. Effects of potentially confounding factors (gender, age, and total cholesterol) were examined by incorporating these as covariates. All P values are two-sided.
Results Both vasoconstrictors produced similar mean effects at each dose in the infused arms of the normotensive and hypertensive groups. The highest dose of N G -monomethyl-L-arginine reduced forearm blood flow by 0.75 ± 0.12 mL min −1 dL −1 (mean ± SEM) in the control group and by 0.89 ± 0.10 mL min −1 dL −1 in the hypertensive group. The study had 90% power (with P = 0.05) to detect a difference of 10-15% in reduction of forearm blood flow during infusion of the highest dose of N G -monomethyl-Larginine.
Conclusions
Reduced sensitivity of forearm resistance vasculature to the vasoconstrictor action of N Gmonomethyl-L-arginine is not a universal feature of essential hypertension.
epithelial sodium channel occurs more frequently in black hypertensive patients (8.3%) than in normotensive black controls (2.1%). This sodium channel mutation could increase the activity of renal epi-thelial sodium channels, resulting in increased tubular sodium reabsorption and hypertension in a similar but less pronounced way to the sodium channel abnormalities that cause Liddle's syndrome. In a family with Liddle's syndrome we have shown that the increase in sodium channel activity can be detected in the nose using transnasal potential difference measurements before and after topical application of the sodium channel-blocking drug amiloride. We therefore measured nasal potential difference in black subjects with the T594M mutation and in a black control population who did not have the mutation.
Nasal potential difference was significantly more lumen-negative in 16 black subjects with the T594M mutation (−26.9 ± 2.6 mV, mean ± SEM) than in 56 hypertensive (HT) black subjects without the mutation (−21.5 ± 0.9 mV) and 21 normotensive (NT) black subjects without the mutation (−20.7 ± 1.3 mV) (P = 0.022). The change in potential after the topical application of amiloride was significantly greater in those with the mutation (12.7 ± 2.0 mV) than in subjects without the mutation (HT 8.5 ± 0.7 mV; NT 6.6 ± 0.9 mV), (P = 0.002). Twenty- Renal renin-angiotensin (RAS) activity is increased in the neonatal spontaneously hypertensive rat (SHR), resulting in increased sensitivity to angiotensin II (Ang II). These alterations in RAS activity have been genetically linked to the subsequent renal abnormalities and high blood pressure of adult SHR. We have recently reported that the SHR pup experiences a period of sodium deficiency, due to impaired maternal milk delivery, which coincides with the reported increase in renal renin activity in these animals. Cross-fostering SHR pups to normotensive WKY dams restores their sodium balance and results in a 20-25% reduction in adult blood pressure. These data suggest that cross-fostering may alter the renal response of SHR pups to Ang II. four hour urinary calcium excretion was higher in subjects with the variant (4.5 ± 0.7 mmol/24h) than in those without (HT 2.8 ± 0.3 mmol/24 h; NT 1.6 ± 0.4 mmol/24 h) (P = 0.016) with no difference in 24 h urinary sodium excretion between the groups (T594M 135.6 ± 16.3 mmol/24 h, HT 126.2 ± 7.4 mmol/24 h, NT 147.1 ± 14.1 mmol/24 h). Plasma renin activity was significantly lower in subjects with the variant (0.14 (0.10 − 0.28) ng/ml/h, median (IQR)) than those without (HT 0.34 (0.12 − 0.81) ng/ml/h, NT 0.38 (0.15 − 0.86) ng/ml/h (P = 0.035).
The findings of increased nasal potential difference measurements in black subjects with the T594M mutation are compatible with an increase in sodium channel activity. Increased sodium channel activity would lead to sodium retention and a corrected state of volume expansion. This supposition is reinforced by the finding of increased urinary calcium excretion and decreased plasma renin activity in this group. These results suggest that the T594M sodium channel mutation could be part of the mechanism that causes the rise in blood pressure in a subgroup of black patients with 'essential' hypertension.
WKY pups and SHR pups reared by their natural mothers or a WKY foster mother (designated SHRX) were anaesthetised with Intraval (thiopentone sodium, 110 mg/Kg, i.p.) and were placed on a continuous i.v. infusion of 0.1448M saline, containing 3 H inulin (0.3 Ci/h), PAH (3 mg/h) and 4.6% albumin, at 25 l/min. Following 2 h equilibration, Ang II was added to the infusate at a rate of 400 ng/Kg/h; control animals continued to receive saline alone. Blood was collected from a carotid artery catheter and urine was collected directly via a bladder catheter for standard clearance measurements.
Mean arterial blood pressure was similar in SHR and SHRX pups (133 ± 6 vs 137 ± 7 mm Hg), but higher than in WKY pups (111 ± 5 mm Hg, P Ͻ 0.05).
Blood pressure did not increase during Ang II infusion. In saline infused rats, renal function was similar in all three groups of rats, with the exception of urine output which was significantly lower (P Ͻ 0.05) in both SHR and SHRX pups, compared with WKY pups. Upon infusion of Ang II, the glomerular filtration rate fell significantly (P Ͻ 0.05) in both SHR and SHRX compared with WKY pups, in accord with their reported increased sensitivity to Ang II. However, Ang II infusion also revealed differences in sodium handling between SHR and SHRX pups. The fractional excretion of sodium 2.1 Insulin-mediated vasodilation and glucose uptake are functionally linked in man SJ Cleland, S Ueda, JR Petrie, HL Elliott and JMC Connell Department of Medicine and Therapeutics, University of Glasgow, West Glasgow Hospitals University NHS Trust, Glasgow, Scotland, UK Background There is a positive relationship between insulin sensitivity and basal endothelial nitric oxide production in healthy volunteers; furthermore, insulin-mediated vasodilation has been shown to be endothelium-dependent. We hypothesised, therefore, that insulin-mediated vasodilation and insulin sensitivity should also be directly related to one another. ) attended on two occasions for measurement of: (1) whole-body insulin sensitivity using the hyperinsulinaemic euglycaemic clamp; and (2) forearm vasodilation in response to a 90-min intraarterial infusion of insulin (5 mU/min) and glucose (75 mol/min) by bilateral venous occlusion plethysmography.
Methods
Results Insulin-mediated glucose uptake (M) for
Cardioprotection and oestradiol: is it a nitric oxide mediated effect?

AC Duncan
Introduction Hormone replacement therapy (HRT) is known to have beneficial effects on the cardiovascular system and there is evidence that these are greater than can be explained by the beneficial effects on serum lipids alone. A number of non-lipid mechanisms of cardioprotection have thus been proposed including a putative improvement in vascular endothelial function.
Methods Using bilateral venous occlusion plethysmography, we have examined forearm vasoconstrictor responses to intra-brachial N G -monomethyl-Larginine (L-NMMA), a substrate inhibitor of nitric oxide synthase, and noradrenaline (NA) a control vasoconstrictor, before and after 4 weeks' therapy with open-label transdermal 17␤ oestradiol (80 g (FE Na ) increased (P Ͻ 0.05) in SHR in response to Ang II, but not in SHRX where the FE Na remained at levels comparable with WKY pups.
SHR pups responded to Ang II infusion by decreasing GFR, as might be expected, and increasing FE Na . Cross-fostered SHRX showed similar changes in GFR but responded to the sodium load in the same way as WKY pups. These data suggest that renal sodium handling by the SHR may be altered by fostering to a WKY dam, possibly as a result of differences in neonatal sodium intake.
the group (mean ± s.d.) was 10.0 ± 2.2 mg/kg/min, while the percentage change in forearm blood flow ratio (%FBFR) for the group (median, interquartile range) was 28.2% (13.6, 48.6). In univariate analysis, M was significantly correlated with %FBFR (r s = 0.60, P Ͻ 0.05), but not with BMI (r s = −0.42), age (r = −0.39) or MAP (r = 0.13). In multiple regression analysis, %FBFR remained a significant independent predictor of M (R 2 (adj) = 0.48, t = 3.23, P Ͻ 0.01) in a model involving BMI, age and blood pressure.
Conclusions From these data, we conclude that: (1) insulin-mediated vasodilation may be an important determinant of insulin-mediated glucose uptake; and (2) glucose uptake modulates the vascular response to insulin, possibly at an endothelial level. We speculate that a functional link between insulin's metabolic and vascular actions may be of importance in the association between metabolic and cardiovascular disorders. daily) in 10 healthy postmenopausal women (age 50 ± 8 years). To compliment this in vivo study, using cultured human aortic endothelial cells (HAEC), we have examined the effect of 17␤-oestradiol (10 pM, 10 nM) treatment for 24 h or 7 days on endothelial nitric oxide synthase (eNOS) messenger RNA synthesis by Northern Analysis.
Results Vasoconstrictor responses to L-NMMA (2, 4, 8 mol/min), which reflect basal nitric oxide synthesis, were as follows: pre-oestradiol 10 ± 13.7, 24 ± 13.1, 29 ± 19.5%; post-oestradiol 10 ± 20.1, 24 ± 13.1, 28 ± 19.5%, ie, no difference in mean response was observed after treatment (P = 0.90, 95% CI −10.7, +9.55: 95% power to exclude a 10% increase). Responses to noradrenaline were similar before and after treatment, but in keeping with recently published data 1 were smaller than those observed in healthy males. Comparison of the oestradiol treated HAEC with untreated controls, using an appropriate internal control (GAP-DH), showed no significant increase in eNOS production following either short term or long term oestradiol treatment. This will be the first presentation of data relating cardiovascular mortality to ambulatory blood pressure (BP) on a significant and as yet unpublished unique cohort of 10 000 patients followed up for a mean duration of 4.3 years and (to date) 328 deaths (The OXAM Study).
Conclusions
The purpose of this study was to identify the prognostic significance of ambulatory BP monitoring (ABPM) over conventional BP measurement for mortality. Much indirect evidence points towards ABPM being more useful at identifying those individuals at risk of CVD but as yet there has been no large scale prospective study to provide firm evidence.
A prospective multi-centre study of ABPM was set up in 48 general practices in Oxfordshire (n = 4500), a hypertension clinic in Oxford (n = 3600), a hyperimprovement in basal endothelial nitric oxide synthesis in post-menopausal women. This observation is further supported by our in vitro study which shows no upregulation of NOS production following oestrogen treatment. 
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Conclusions
The present data suggest that whole body NO production is higher in healthy women than in men under basal conditions. The origin of NO measured in this study cannot be determined but the difference in production shown in this trial may underlie differences in vascular function between males and females. tension clinic in London (n = 1400), and a random cohort study in Oxford City (n = 500). ABPM was performed on 10 376 patients using the A&D TM2420 version 7 monitor from 1992 onwards. Information about cardiovascular risk factors was collected.
Preliminary analysis confirms that ABPM identifies a different group of patients at risk from that detected using conventional office BP measurements both within general practice and hospital medicine. The presence of white coat hypertension in general practice was 7% (office systolic BP Ͼ160 and diastolic BP Ͼ90 mm Hg; ambulatory systolic BP Ͻ135 & ambulatory diastolic BP Ͻ85 mm Hg).
The problems associated with determining thresholds for definition of risk are well known. We will be presenting data in a novel way that overcomes some of these difficulties.
We will present data on the all cause mortality seen in patients who have white coat hypertension compared with those who are normotensive or hypertensive on ABPM. The contribution of ambu- Background Left ventricular hypertrophy (LVH) is a powerful independent predictor of cardiovascular mortality. The ECG is insensitive at detecting LVH while echocardiography (echo) is both time-consuming and expensive. Black hypertensives have an increased prevalence of both ECG-LVH and echo-LVH compared to whites. However the ethnic difference in prevalence of ECG-LVH is more marked than the difference seen in prevalence of echo-LVH. This has led to the proposal that ECG voltage criteria for LVH are less specific in blacks than whites.
ECG detection of left ventricular hypertrophy is better in blacks than whites
Objective To evaluate the proposal that ECG criteria for LVH are less specific, and hence less useful, in blacks than whites.
Methods This was a retrospective cross-sectional study of ECG and echo indices of LVH in a biracial population referred to a hypertension clinic. Blood pressure, ECG (Sokolow-Lyon and Cornell sexspecific) voltages and echocardiographic LV mass index (LVMI) were measured on 408 consecutive subjects (271 white, 137 black). Ethnic differences in sensitivity, specificity and predictive value of the ECG in the detection of LVH were sought. Despite these observations, this useful physiological modality has not featured in routine clinical practice. One reason is that there is lack of uniform agreement regarding study protocol and equipment. This study introduces the Dundee step test and discusses the rationale behind it.
Methods The Dundee step test is a light, single stage, sub-maximal exercise test with a workload equivalent to 5 Mets (17.5 ml/kg/min O 2 uptake). Each test lasts for 5 min and exercise BP is measured during exercise. Healthy volunteers have been studied to assess reproducibility and to provide data for normal ranges. In addition a comparative study has latory BP with other cardiovascular risk factors, to all cause mortality, calculated using regression analysis will also be presented.
ECG criteria were twice as sensitive in blacks as whites (Sokolow-Lyon: 44.9 vs 22.5%, P = 0.003. Cornell: 30.4 vs 15.7%, P = 0.03). ECG criteria were less specific in blacks using the Sokolow-Lyon criteria (73.5 vs 86.8%, P = 0.02) but this failed to reach significance using the Cornell criteria (83.8 vs 91.8%, P = 0.07). The improved positive predictive value of the ECG in blacks compared with whites failed to reach significance (65.6 vs 48.3%, P = 0.17). Correlations between ECG voltages and echo-LVMI tended to be better in blacks than whites for both Cornell (correlation coefficient r = 0.449 and 0.415 respectively, P = NS) and Sokolow-Lyon voltages (r = 0.307 and 0.234, P = NS).
Conclusions
In both ethnic groups, the usefulness of the ECG in detecting LVH remains limited by poor sensitivity. In our population, the sensitivity and positive predictive value of ECG detection of LVH was better in blacks than whites with only a small loss of specificity. Since correlations between ECG voltages and LVMI tend to be better in blacks than whites, it appears from this data that the greater ethnic differences in the prevalence of ECG-LVH compared with echo-LVH are mainly due to decreased sensitivity in whites rather than decreased specificity in blacks. In the assessment of cardiovascular risk, detection of LVH has powerful prognostic value. In this context, the ECG is of greater value in blacks than whites.
been carried out to assess exercise BP measurements using both step test and bicycle ergometry. A group of hypertensive subjects have also been exercised off drug therapy to assess their BP responses to exercise. In addition, a group of treated hypertensives with controlled BP were exercised.
Results Exercise SBP measured with the step test correlated with that of bicycle ergometer (n = 37, r = 0.93, P Ͻ 0.01). Data from healthy volunteers (n = 90, resting BP р140/90 mm Hg) suggested that an exercise SBP of у180 mm Hg was above the 95th percentile indicating an abnormally high SBP during exercise. There was a significant positive correlation between exercise SBP and increasing age (r = 0.55, P Ͻ 0.01). This was also present in untreated hypertensive subjects [n = 27, 13 males, mean age of 41 (9) years, clinic BP 153(20)/98(9) mm Hg] (n = 27, r = 0.45, P = 0.013), but the slope of the relationship between exercise SBP and age was significantly different, and it was seven times steeper. Of the 41 subjects [20 males, mean age of 55 (SD 10, range 29-74) years, clinic BP 137(13)/85(7) mm Hg] with controlled clinic BP, 14 (34%) has exercise SBP у180 mm Hg.
Conclusions The Dundee step test is quick and reproducible, and may be prognostically useful. The test is suitable for use in the clinic setting and for
Estimation of cardiovascular risk in hypertensive patients in primary care
AA Montgomery, T Fahey, TJ Peters, C MacKintosh and DJ Sharp Division of Primary Health Care, University of Bristol, Canynge Hall, Whiteladies Road, Bristol BS8 2PR, UK Introduction and aims New Zealand (NZ) guidelines for the management of hypertension are the most explicit in stratifying according to absolute cardiovascular risk. Other guidelines acknowledge the importance of other cardiovascular risk factors, but these guidelines imply that doctors are able to assimilate the necessary information and make an accurate estimate of risk. This study aimed to compare estimates of risk in elderly hypertensive patients made by general practitioners/practice nurses with a 'gold standard' calculated using individual patient data and a multiple regression equation derived from Framingham study data.
Methods Data were collected as part of a randomised controlled trial investigating the use of a computerised clinical decision support system in the management of hypertension. General practitioners (n = 69) and practice nurses (n = 11) from 23 general practices in Avon made estimates of the 5-year risk of suffering a cardiovascular event in a group of elderly hypertensive patients. Risk was estimated on a seven-point scale and expressed as either absolute risk (AR) or the equivalent number needed to treat to prevent one cardiovascular event (NNT). The 'gold standard' risk was calculated using individual Background Ambulatory blood pressure monitoring (ABPM) allows the recognition of a number of clinically identifiable BP sub-types. These have distinct age and sex profiles, suggesting that they may also have distinct aetiologies. It remains to be seen whether they have separate outcomes with respect to prognosis.
Aims To compare the changes in left ventricular epidemiological studies. About a third of patients with controlled clinic BP had uncontrolled BP on exercise. This might account for the increased morbidity since in treated hypertensives.
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1 Filipovsky J, Ducimetiere P, Safar ME. Prognostic significance of exercise blood pressure and heart rate in middle-aged men. Background From 10% to 20% of hypertensives currently on medication have white coat hypertension (WCH). 1 It has a degree of risk between that of normotension and sustained hypertension 2 and most patients do not need drug treatment unless the blood pressure (BP) is very high or they have other major cardiovascular risk factors. It can only be diagnosed by using ambulatory or home BP monitoring.
Aims To determine how general practitioners used home monitoring to diagnose WCH and how it changed patient management. To investigate the patient, nurse and doctor acceptability of the use of Conclusion ABPM identifies BP sub-forms which have epidemiologically distinct age and sex profiles. Analysis of ECG criteria of LV mass in a large referral population of hypertensives shows that these sub-forms have different end organ profiles, with WCH, BH and IDH showing relatively lower LVH values, and ISH, SDH and INH relatively higher scores.
semi-automatic digital electronic sphygmomanometers in home BP monitoring.
Methods
The sphygmomanometers (Omron 705CP) were used by 20 practices (83 GPs) to monitor patients before initiating or increasing medication. Patients measured their BP at home 14 times over 5 days and recorded it on a chart and in the instrument's memory. Doctors made patient management decisions on the basis of home and prior office readings using recognised definitions. 3 Patients, nurses and doctors completed questionnaires and took part in focus groups on the use and acceptability of DES.
Results 537 patients were monitored. 28% were over 65 years of age and 56% were female; 64 (27%) of the 236 untreated had WCH and no medication was started in 60 (94%) of this group; 45 (17%) of the 258 poorly controlled patients had WCH and of these, 76% continued with the same medication and 24% either reduced or stopped it. Compliance with recording was high with 81% of patients making 14 recordings and 98% at least 10. Two refused monitoring and one was unable to use the monitor. Only 4% of the remainder reported any major problems with monitoring; 6% said that recording interfered in some way with normal living, the commonest being the necessity to stop work whilst using the monitor; 14% found cuff inflation to be very uncomfortable or painful. Questionnaires and focus groups showed a high degree of interest and satisfaction with monitoring for patients, doctors and nurses. Objectives (a) To develop a new approach to the analysis of blood pressure and heart rate data obtained by radio-telemetry monitoring, using nonparametric statistical methods known as local regression models; (b) to assess the effects of three pharmacological interventions on cardiac and vascular hypertrophy in the stroke prone spontaneously hypertensive rat (SHRSP).
Conclusions
Design and methods
Using the Dataquest IV Telemetry System, intra-arterial systolic (SBP) and diastolic (DBP) pressures were measured for 4 weeks in four groups of SHRSP that were between 16 and 20 weeks of age. Six animals (group denoted by L) received 40 mg/kg/day of losartan, six received 2 mg/kg/day of perindopril (P), and six received 4 mg/day each of hydralazine and hydrochlorothiazide (H). Ten animals were maintained as controls (C). Seasonal and Trend decomposition using Loess (STL) was used to split each time series into overall trend, cyclic and residual components, and local regression models were used to compare group effects in an analysis of covariance. Vascular smooth muscle polyploidy, a measure of large vessel hypertrophy, was determined with flow cytometry DNA analysis (Becton-Dickinson), and expressed as the percentage of cells in G 2 + M phase. Cardiac hypertrophy was expressed as left ventricle (LV) to body weight ratio (in mg/g).
Results
All three treatments resulted in highly significant reductions of SBP and DBP (P Ͻ 10 −6 for use and had many fewer problems than is commonly reported with the use of continuous ambulatory monitoring. Nurses and doctors thought that home monitoring represented a valuable enhancement of their management of hypertensive patients. Most thought it more feasible than ambulatory monitoring, though most had no first-hand experience of this. The monitor costs about £160 whereas ambulatory monitoring would be several thousand pounds and has other disadvantages. The feasibility of diagnosing WCH with home BP monitoring was demonstrated and, for this specific purpose, it is recommended as the preferred alternative to ambulatory monitoring. each vs C). The magnitude of the hypotensive effect was comparable for L and P. The H group displayed a less hypotensive trend (H vs L or P; P Ͻ 10
References
−6
). The cyclic behaviour of SBP and DBP was most altered in the H group (P Ͻ 10 
Conclusions
The STL and local regression analysis of these telemetry data allowed for assessment of trends and periodicity of direct intra-arterial blood pressure measurements and for accurate prediction of the regression of end-organ damage in genetic hypertension. It seems that pharmacological interventions that inhibit the renin-angiotensin system result in regression of cardiac and vascular hypertrophy and that these effects are linked to both overall trends and the cyclic behaviour of direct intraarterial pressures. Background Hypertension (HPT) is associated with abnormalities in calcium metabolism (such as hypercalciuria and secondary hyperparathyroidism). Cross-sectional studies have reported an independent association between HPT and prevalent kidney stone (KS) disease. However, no prospective study has established whether raised blood pressure (BP) precedes the development of kidney stones or it is the result of kidney damage in stone-formers.
A prospective study of hypertension and the incidence of kidney stones in men
Objective To examine whether HPT predicts the incidence of KS disease over 8 years among middleaged men.
Design and Methods
The Olivetti Heart Study is a longitudinal study of middle-aged working men in Southern Italy. Five hundred and three men with negative history of KS (age range 21-68 years), who were seen in 1987, were re-examined in 1994 -1995. Follow-up rate was 87%. HPT was defined as BP у160 and/or у95 mm Hg or on drug therapy at baseline. Anthropometry, BP and history of KS were evaluated both at baseline and at the 8-year followup visit. Occurrence of KS was defined as radiological or echographic evidence or documented passage of one or more stones. Creatinine clearance was taken as an index of renal function and fractional excretion (FE) of sodium as an index of sodium intake. Objectives Bias in office blood pressure measurement (OBP) manifests itself in terminal digit preference (TDP) and in heaping (preference for diagnostic values). The objective of this study is to compare the degree of TDP and heaping in OBPs measured by general practitioners (GPs), blood pressure unit nurses.
Terminal digit preference and heaping in office blood pressure measurements
Methods From the DABL98 database of almost 20,000 ambulatory blood pressure measurement (ABPM) visits, 1722 referred patients had measurements from both sources. The first sample from their ABPM was also included as a control. The frequency of each value and of their terminal digits were analysed.
Results GPs expressed a particularly strong preference for zeros (90%/77% (SBP/DBP)) and were the only group to express a preference for fives (5%/15%). Other digits were rarely used. Nurses expressed similar results for both SBP and DBP with around 28% for zero and around 16% for the Results At baseline 114/503 (22.7%) had HPT and 32 were on drug treatment. Hypertensives were older and heavier than normotensives, and had comparable renal function and FE of sodium. After 8 years 52 (10.3%) incident cases of KS were detected. The majority (45) Conclusions Hypertension in middle-aged men is a significant predictor of KS disease in a prospective study, possibly through the greater and sustained urinary calcium losses seen in hypertensive people, irrespective of their sodium intake. These findings have important implications for the early detection and prevention of kidney stone disease and its recurrence amongst hypertensive people.
remaining even digits with a slight bias against two and eight. Odd digits were rarely used. The automatic results were, as expected, evenly distributed across all ten digits. GPs also expressed the most obvious heaping. The strongest preferences for SBP were 150 (8%), 160 (17%), 170 (12%), 180 (17%), 190 (7%) and 200 (12%) and for DBP were 100 (30%), 110 (23%) and 120 (10%). Dihydropyridine-sensitive calcium channels play a major role in excitation-contraction coupling in vascular smooth muscle and are the therapeutic target for calcium channel antagonists. Calcium channel antagonists have been shown to inhibit migration and proliferation of cultured animal-derived cells, and to reduce atherogenesis and the response to injury in animal models. However, evidence of antirestenotic or anti-atherogenic activity of calcium channel antagonists in humans remains unconvincing. This study has examined the role of dihyrdopyridine-sensitive calcium channels in calcium entry and migration of human vascular smooth muscle cells in response to known mitogens/chemotactic factors, platelet-derived growth factor (PDGF-BB) and thrombospondin (TSP-1). In addition, the possibility that the role of Ca 2+ channels in responses differed depending on differentiation state was examined by induction of growth arrest in cultured cells.
Explant-derived, cultured human saphenous vein smooth muscle cells (HVSMC) at passage 2 were used in all studies. Cells were routinely cultured in DMEM containing 15% foetal calf seum. Growth arrest was induced by serum deprivation for 7 days. Migration in response to a chemotactic gradient was measured using a Boyden chamber and intracellular Ca 2+ ([Ca 2+ ] i ) was measured in cell suspensions loaded with the fluorescent indicator fura-2. Cellular differentiation was examined using immunocytochemistry for cytoskeletal markers including smooth muscle and non-smooth muscle isoforms of ␣-actin, smooth muscle myosin heavy chain isoforms, caldesmon, and by Western blotting for smooth muscle ␣-actin. Background Two common polymorphisms causing amino-acid substitutions in the N-terminus of the ␤ 2 -adrenoceptor have been described. 1 A→G at base position 46, which results in amino-acid change Arginine16→Glycine and C→G at base position 79, resulting in amino-acid change Glutamine27→Glutamate. Functional studies of these variants using site-directed mutagenesis and subsequent recombinant expression revealed that the Arginine 16→Glycine variant demonstrates an inclination to overestimate blood pressure remains, accurate automatic measurements are essential for correct diagnosis.
In cells grown in 15% foetal calf serum (randomly cycling) a dihydropyridine calcium antagonist, amlodipine (10 −5 M; n = 5) had no effect on migration of HVSMC in response to PDGF-BB (2 ng/ml) or thrombospondin-1 (10 g/ml). BAYK8644, a calcium channel agonist, also had no effect on responses to PDGF-BB (n = 4). Amlodipine (10 Dedifferentiated proliferating HVSMC do not express a functionally significant population of dihydropyridine-sensitive calcium channels and Ca 2+ enters by routes insensitive to these Ca 2+ antagonists. Assuming that human intimal cells exist in a dedifferentiated 'synthetic' state, these observations may explain the comparative failure of calcium channel antagonists to prevent atherosclerosis and restenosis in man compared with animal models. increased agonist-promoted downregulation but that the Glutamine27→Glutamate variant is completely resistant to downregulation. 2 Importantly, expression of both variants together, however, had the same effect on downregulation as the Arginine 16→Glycine variant alone. Changes in agonist-promoted regulation might alter vascular reactivity and therefore affect blood pressure and recently the Arginine16→Glycine variant has been associated with essential hypertension in an African Caribbean population. 3 Previous studies have examined these functionally opposing variants individually, we wished to assess the relationship between them in essential hypertension.
Methods DNA was extracted from blood samples taken from 238 patients with mild to moderate essential hypertension; mean blood pressure off treatment: systolic 162.7 (s.d. 14.1), diastolic 101.4 (s.d. 4.62). The patients were then genotyped for both polymorphisms using a fluorogenic 5Ј nuclease, assay. This assay utilises PCR and the 5Ј exonuclease activity of Taq polymerase to cleave a fluorescent dye from an allele specific probe. For each variant two probes were used, one specific for each allele and labelled with a different fluorescent dye facilitating allelic discrimination. The accuracy of this technique for genotyping was assessed by comparison with the results of fluorescent sequencing of DNA from a random sample of 50 patients.
Results DNA of suitable quality was obtained from 229 patients. In 18 cases the probe/primer design was not able to distinguish adequately the genotype for one or other variant. The sequencing data confirmed the high degree of accuracy of the technique for the remaining 211 samples. The genotype frequency for the first variant was; Arg16/Arg16: 10%, Arg16/Gly16: 55%, Gly16/Gly16: 35% and the second was Gln27/Gln27: 34%, Gln27/Glu27: 50%, Glu27/Glu27: 16%. Although all genotypes were Aims The aims of the present study were: (1) to determine whether cAMP elevation by other means can increase NOS activity in HUVEC; and (2) to ascertain whether ␤-AR stimulation or cAMP elevation cause a concomitant increase in L-arginine transport.
Methods HUVEC were isolated from fresh umbilical cords using a standard collagenase digestion method, and grown to confluence at passage 3 in 24-well plates (for NOS activity assays) or 96-well plates (for L-arginine transport measurements).
common, the Glu27/Glu27 variant only occurred in association with the Gly16/Gly16. Furthermore in no cases which were Arg16/Arg16 was the Glu27 allele found. Therefore the Glu27 allele appears to occur only in the presence of the Gly16 allele in this population.
Conclusions Several workers have examined the relationship between alterations of amino-acid 16 and/or 27 in the ␤ 2 -adrenoceptor and diseases such as asthma and hypertension. We have assessed the relationship between these two variants. Gly16 is common and in vitro confers greatest agonist-promoted downregulation. Arg16 is less common and associated in vitro with some loss in downregulation. The genotype Arg16/Arg16 + Glu27/Glu27, which in vitro causes complete resistance to downregulation is not found in this population of 211 patients with essential hypertension.
L-Arginine transport
Following 30 min equilibration of HUVEC with 100 M unlabelled L-arginine, cells were exposed to agonists (concentrations as above) or vehicle for 5 min; they were then washed and exposed to [ 3 H] L-arginine (2.0 Ci/mL) for 30 sec, followed by washing with ice-cold stop solution containing 10 mM unlabelled L-arginine. Radioactivity was measured in formic acid cell digests by liquid scintillation counting. All experiments using cells from each umbilical cord were performed in quadruplicate. Data were analysed by one-way ANOVA, with statistical significance taken as P Ͻ 0.05 (two-sided). Results are presented as mean ± SEM. Voltage-operated calcium channels are the dominant route of Ca 2+ entry into vascular smooth muscle cells and play a major role in excitation contraction coupling in smooth muscle. Mechanisms influencing calcium channels in vascular smooth muscle are likely to be important in physiological and pathophysiological changes in vascular tone and peripheral resistance. We have previously demonstrated that endogenous tyrosine kinases are an important regulator of voltage-operated calcium channels in arterial smooth muscle cells. Recent evidence indicates a key role for an endogenous tyrosine kinase, src kinase, in this effect. 1 However, the overall level of tyrosine phosphorylation in the cell represents a balance between the activity of tyrosine kinases and tyrosine phosphatases (PTPases). At present the possible role of endogenous PTPases in calcium channel regulation in vascular smooth muscle is unknown and their regulation is poorly understood. This study has examined the potential role of PTPases as regulators of calcium channel opening and hence Ca 2+ entry and vascular tone. Single arterial smooth muscle cells were freshly isolated from rabbit ear artery using an enzymatic technique.
Results
1 Calcium channel currents (I Ba ) were studied by whole cell voltage clamp techniques using 110 mM Ba 2+ as charge carrier. All experiments were conducted at room temperature. In addition to voltage clamp experiments rabbit ear artery cells were lysed, homogenised and used in immunoblotting studies to confirm the effectiveness of peroxyvanadate as an inhibitor of PTPases. Data presented are means ± SEM of n observations.
In the absence of any drug I Ba evoked by a 20 ms depolarization from −60mV to +10mV were 48 ± nificantly: 2.0 ± 0.2 (n = 10), 2.3 ± 0.3(n = 10) and 2.0 ± 0.3 (n = 7) pmol/g protein/min respectively.
Conclusions
We conclude that ␤-AR stimulation increases L-arginine transport and NOS activity, in HUVEC. Agents which increase cAMP independently of the ␤-AR also produce the same effects. Our findings provide the first direct evidence that ␤-AR and cAMP can activate the L-arginine/NO system in isolated endothelial cells.
3pA (n = 6) and were stable over 5-10 min study period. Intracellular application of the PTPase inhibitors, sodium orthovanadate (100 M) and peroxyvanadate (100 M) increased I Ba by 56 ± 16% (n = 4) and 91 ± 21% (n = 4), respectively. Bath application of two other membrane permeant PTPase inhibitors, phenylarsine oxide (100 M) and dephostatin (50 M) also increased I Ba by similar amounts (48 ± 7% (n = 8) and 52 ± 10% (n = 4), respectively). Although the magnitude of currents was increased, inhibition of PTPase had no significant effect on the voltage-dependence of activation or inactivation of I Ba as estimated from current-voltage relationships and steady-state inactivation data respectively. Western blotting studies showed that peroxyvanadate (100 M) increased tyrosine phosphorylation of several proteins (MW = 27, 42, 45, 64, 87 and 93 kDa) confirming its action as a PTPase inhibitor (n = 3). The selective tyrosine kinase inhibitor, tyrphostin-23 (100 M) reduced calcium channel currents by 44 ± 4% (n = 4) and abolished the effects of the tyrosine phosphatase inhibitors on calcium channel currents (n = 4 -5). These results indicate that endogenous PTPases modulate calcium channels in arterial smooth muscle cell by influencing the level of tyrosine phosphorylation of cellular proteins. Regulation of PTPase activity may represent a novel mechanism responsible for calcium channel regulation and vascular tone. Introduction Untreated essential hypertension is associated with measurable psychomotor performance (PP) impairment. This is reversible within a week of starting antihypertensive medication and seems to be a non-drug specific effect of lowering blood pressure (BP). 1 A vascular mechanism has been postulated to explain this phenomenon. SPECT has previously failed to show any differences in regional cerebral blood flow in hypertensives on and off treatment. 2 Functional magnetic resonance imaging (FMRI) is a relatively new functional imaging technique that offers superior temporal and spatial resolution over PET and SPECT. FMRI has shown that dorsolateral prefrontal cortex (DLPFC) activation occurs during a working memory task 3 and there is evidence to suggest that for a particular region of interest the volume of brain activated is a function of the ease with which an individual completes a task (eg, a working memory paradigm). 4 The hypothesis under test is that in patients with hypertension the fall in BP with treatment is associated with a reduction in the area of activated cortical regions during FMRI compared to placebo.
Functional magnetic resonance imaging-a novel
Methods Using a double blind two period crossover design three right-handed male hypertensives (mean age 71 years) received placebo and amlodipine in random order. At the end of each treatment period subjects underwent psychomotor performance assessment and FMRI employing a verbal working memory paradigm.
3 Gradient-echo echoplanar MR images were acquired using a 1.5 Tesla GE Signa System at the Maudsley Hospital, London. T2*-weighted images depicting BOLD contrast were acquired over 5 min with an in-plane resolution of 3 mm (TE 40ms, TR 3s) at each of 14 near-axial noncontiguous 7 mm thick slices parallel to the AC-PC line. Image analysis was by non-parametric analysis and generic brain activation mapping. 5, 6 Results Mean BP on placebo and amlodipine was 184/103 and 155/86 mmHg respectively. PP improved on treatment, e.g., mean choice reaction time fell from 0.811 to 0.674 sec. 6 Left DLPFC activation was observed as expected, and was substantially greater in the placebo state (Figure) . There was a different pattern of cortical activation in the pla- L  17  1  2  DLPFC  L  13  1  3  PVC  R  7  2 cebo state, including increased cerebellar and primary visual cortical activation (PVC) ( Table) .
Conclusion
These pilot data are the first FMRI data in hypertension. The results are consistent with our hypothesis that patients with untreated hypertension have to recruit a larger neural net to complete a given task as their brains are functionally compromised. They are also compatible with the hypothesis that the abnormality is functional not structural. There is a controversy about the relationship between salt intake, water intake and blood pressure. Studies in animals have demonstrated that a high salt intake significantly increases renal excretion of water with an increased water intake. However, in man, it is less clear how far salt intake determines fluid intake and furthermore, if there is a relationship between fluid intake and blood pressure, how far is it confounded by differences in salt intake. Two studies were carried out. In the first, 634 patients with essential hypertension on no treatment had measurements of 24-h urinary sodium and volume on their usual sodium intake. There was a significant correlation between urinary volume and urinary sodium excretion b(1/mmol) = 0.0045, r = 0.38, P Ͻ 0.001. This correlation was still significant when corrected for age, gender, systolic and diastolic blood pressure, urinary creatinine and potassium excretion. A difference in salt intake from 275 mmol to 20 mmol predicted a urine volume change of 1148 ml.
Effect of salt intake on renal excretion of water
In the second, 104 patients with essential hypertension were studied on their normal diet, a high sodium intake of 350 mmol/day for 5 days and a low sodium diet of 10 mmol/day for 5 days with no advice about fluid intake. Mean age was 48 years. There were 48 men and 56 women; 71 were white and 33 were black. On the normal diet, the mean 24-h urinary volume was 1559 ml with a urinary sodium excretion of 147 mmol/24h. After 5 days on the high-salt diet, urinary volume increased to 2155 ml (urinary sodium 274 mmol/24h). After 5 days on the low-salt diet, urinary volume decreased to 1312 ml (urinary sodium 21 mmol/24h). There was a 6.1 Differences in birthweight between twins and subsequent differences in blood pressure levels Background Significant associations have been reported between low birth weight and cardiovascular morbidity and adverse levels of various cardiovascular risk factors including blood pressure (BP). However criticisms of these reports include the possible confounding effects of various maternal characteristics such as smoking or propensity to hypertension on the observed associations. The investigation of heavier and lighter twins ensures matching of any such maternal variables and hence overcomes confounding of this type. Hence the association between birth weight differences in twins and the differences in their adult BP levels was evaluated.
Methods As part of the St Thomas's adult twin register study, same sex unselected twins were highly significant correlation between the reduction in urinary volume on going from the high to the lowsalt diet and the decrease in urinary sodium excretion (r = 0.50, P Ͻ 0.001). This correlation was still significant when corrected for age, gender, the changes in systolic and diastolic blood pressure, urinary creatinine and potassium excretion. The average reduction in urinary volume was 843 ml (P Ͻ 0.001) from the high to the low-salt diet, which was very similar to the predicted change derived from the larger number of hypertensive subjects studied on their usual diet.
In hypertensive patients on their usual diet, the greater the salt intake the greater the renal excretion of fluid. When salt intake is decreased from a high to a low sodium intake there is a fall in urine volume. This difference in urine volume is very similar to the difference seen in free living individuals. These results clearly demonstrate that salt intake is one of the major factors controlling urine volume and therefore fluid intake and that the difference in urine volume between individuals and between populations is likely to be more related to differences in salt intake rather than any direct relationship between urine volume and blood pressure. Our findings are also important in that they clearly document a quantitative relationship between salt intake and fluid intake and have major implications for the soft drink industry. For instance, if the COMA cardiovascular recommendations to reduce salt intake from 9 to 6 grams were implemented, the fluid intake in the whole population would fall by approximately 250 ml/day (ie, equivalent to one soft drink per person per day).
recruited via a media campaign throughout the UK. Twins attended St Thomas's Hospital and underwent examination and investigation including sitting BP measurement using the OMRON HEM705CP under standardised conditions. Recalled birth weight was recorded and validated where possible against birth records. Data on 641 pairs of twins (mean age 54 years: range 19-76) were recruited; 492 pairs (76.8%) provided self-reported birth weights on both twins. Of these, 479 pairs of twins had BP levels recorded, of which 80 pairs of twins reported the same birth weight as each other. Differences in reported birth weight between twins among the remaining 399 pairs were categorised as 1-500, 501-1000 and Ͼ1000 g.
Results
The mean differences in systolic and dias- Background All automated blood pressure measuring equipment should be assessed for accuracy in the population for which it is intended before being relied upon in clinical practice. A new wrist monitor, the Omron Rx uses an oscillometric technique to measure blood pressure. The recent move to ban mercury from clinical areas has increased the need to consider alternative devices, however these must be fully evaluated before use. It is compact and light (150 grams) and therefore easily portable and very convenient for monitoring blood pressure away from the clinical environment. In addition it is relatively comfortable during its inflation cycle compared to cuffs which inflate over the upper arm.
Objective The aim of this study was to determine the accuracy of the Omron Rx wrist monitor in 85 adults with a wide range of blood pressure, following the British Hypertension Societies (BHS) protocol. To our knowledge no other wrist monitor has undergone accuracy assessment by such a stringent protocol.
Method The BHS protocol was followed, which includes assessment of the device in use, as well as a comparison between the device and mercury sphygmomanometry (using two blinded trained observers).
The results are shown in the Several previous epidemiological studies have demonstrated an association between physical activity and the incidence of hypertension.
1 Physical activity is a complex and multi-dimensional exposure and in each of these studies it was assessed using questionnaires which are subjective, non- between observer and device for systolic and diastolic respectively. An acceptable BHS grade B was achieved. The absolute differences between device and observer were within 5 mm Hg, although the standard deviation of the differences were more than 8 mm Hg. It therefore narrowly failed to meet the American Association for Medical Instrumentation criteria (AAMI) (р5 ± 8 mm Hg). However AAMI criteria is based on simultaneous comparisons between test device and observer instead of sequential comparisons as recommended by the BHS protocol. Therefore we do not believe this precludes its use in clinical practice.
Discussion
The Omron Rx wrist monitor achieves a grade B in adults with a wide range of blood pressures, as defined by the BHS protocol. The measurements obtained by the Omron Rx, can therefore be relied upon as a suitable alternative to conventional sphygmomanometry.
quantitative, and do not clearly specify the dimension of the exposure that is being measured. Thus, it is uncertain whether the observed associations are with participation in vigorous activity or with total energy expenditure. Heart rate monitoring with individual calibration using the HRFlex technique is an objective and noninvasive method which can be used in populationbased studies to measure total energy expenditure. 2 It has previously been validated against the gold standard techniques of doubly-labelled water and whole body calorimetry.
3
A cross-sectional study was undertaken in the context of a continuing population-based cohort study. 4 A total of 770 subjects aged 45-70 years underwent 4-day heart rate monitoring. Individual calibration of the relationship between heart rate and energy expenditure was undertaken in each subject using the standard HRFlex protocol. 3 Total energy expenditure was computed as the physical activity level (PAL), the ratio of total energy expenditure to basal metabolic rate. Systolic and diastolic blood pressure were measured using an Accutorr sphygmomanometer, and are presented as the mean of three readings.
The table shows the strong linear relationship between PAL and age-adjusted systolic and diastolic blood pressure (linear trend P Ͻ 0.001) and the magnitude of the difference between top and bottom quintiles.
The negative association of PAL with both systolic and diastolic blood pressure was still observed in 6.5 Blood pressure levels and hypertension status among ethnic groups in the health survey for England control rates in people of black (combining blackCaribbean, black-African and black-other), South Asian (combining Indian, Pakistani and Bangladeshi) and white origin. Three sitting BP's were measured using the Dinamap 8100 device. BP values presented are the mean of the last two readings. Every year the ethnic minority sample was around 5% of the total. The white sample was on average older than the non-white. This analysis is restricted to people aged 40 and above.
Results Age-adjusted mean BP's and prevalences of hypertension* are shown in the table by race and sex. The odds of being hypertensive were higher in black men (odds ratio [OR] 2.0;95% CI 1.4,2.9: P Ͻ0.001) and women (OR 1.7;95% CI 1,2,2.5: P Ͻ 0.01) than in their white counterparts, after con-trolling for age, BMI, smoking, drinking, and social class. The adjusted OR was also significantly higher for South Asian men (1.9; 95% CI 1.4, 2.4: P Ͻ0.001) while South Asian women had a non-significantly lower risk (OR 0.9; 95% CI 0.6, 1.2). Hypertensive South Asian men and women were less likely, while blacks were more likely to be treated for their hypertension than whites. However differences were not significant after controlling for potential confounders. Among those taking anti-hypertensive medication, less black men and South Asian women achi-6.6 Management of renovascular disease: review of renal artery stenting in ten studies Baseline clinical details Stents were placed in 416 renal arteries in 379 patients. Their average age was 64 (range 27-84) and 56% were male; 97% of the stenoses were atheromatous (range 71-100% in different studies), 80% were ostial (range 37-100%) and 31% were bilateral (range 12-87%). The clinical indication for stenting was usually hypertension with or without mild renal impairment. None of the studies included patients with pulmonary oedema.
Technical aspects Radiological indications for stenting were narrowing of at least 50% (in nine of the 10 studies) as a result of elastic recoil (58%) or dissection (2%) at the time of angioplasty; restenosis some time after angioplasty (15%); or as a primary procedure (25%). Technical success, using four different criteria, was reported in 96-100% cases. Restenosis, defined as у50% narrowing and evaluated in 312/416 (75%) arteries, generally between 6 and 12 months, was 16% overall but only 11% in the five most recent studies.
Blood pressure All 10 studies categorised blood pressure (BP) after stenting as cured, improved or failed. None gave a formal trial of medical therapy before stenting, described their technique of BP eved BP control (SBP Ͻ160 mm Hg and DBP Ͻ95 mm Hg) compared with whites, but differences were not statistically significant after adjustment.
Conclusions Black men and women, and South Asian men, are at higher risk of hypertension than whites after controlling for age, social class, BMI, smoking and drinking. Levels of treatment and control do not appear to be significantly different among whites, black and South Asian adults in England. measurement, or reported serial measurements of BP before and after stenting; 34/379 (9%) patients were cured by stenting (DBP р90 mm Hg on no treatment). The category of improved BP was considered to be insufficiently robust for analysis.
Renal function This was judged by serum creatinine concentration (SCC) to have improved, stabilised or deteriorated. One study, with an average baseline SCC Ͼ200 mol/l, reported serial measurements of SCC before and after stenting and showed that successful stenting can slow the rate of progression of renal failure in patients whose renal function is deteriorating beforehand. Baseline SCC was Ͻ200 mol/l in the remaining nine studies and did not change with stenting.
Complications 6/379 (1.6%) patients died within 30 days of stenting but in only 2/379 (0.5%) was death judged to have been related to the procedure. Complications, as reported by the authors, occurred in 46/379 (12%). Half of these required some form of intervention, ranging from blood transfusion to temporary or permanent dialysis.
Conclusions
None of the studies compared stenting with any other treatment modality, yet all 10 concluded that stenting is technically feasible, without major complication and an effective form of therapy for ostial stenoses. Examination of the results in these studies suggests that the benefits for BP and renal function may have been less than was claimed. For the time being stenting should be offered by specialist centres as a secondary procedure for unsuccessful angioplasty, or restenosis following angioplasty, to patients with renovascular disease and uncontrolled hypertension, advancing renal failure or pulmonary oedema.
